• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类乳酸脱氢酶及恶性疟原虫乳酸脱氢酶的选择性抑制剂。

Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum.

作者信息

Deck L M, Royer R E, Chamblee B B, Hernandez V M, Malone R R, Torres J E, Hunsaker L A, Piper R C, Makler M T, Vander Jagt D L

机构信息

Departments of Chemistry and of Biochemistry and Molecular Biology, University of New Mexico School of Medicine, Albuquerque, New Mexico 87131.

出版信息

J Med Chem. 1998 Sep 24;41(20):3879-87. doi: 10.1021/jm980334n.

DOI:10.1021/jm980334n
PMID:9748363
Abstract

Derivatives of the sesquiterpene 8-deoxyhemigossylic acid (2, 3-dihydroxy-6-methyl-4-(1-methylethyl)-1-naphthoic acid) were synthesized that contained altered alkyl groups in the 4-position and contained alkyl or aralkyl groups in the 7-position. These substituted dihydroxynaphthoic acids are selective inhibitors of human lactate dehydrogenase-H (LDH-H) and LDH-M and of lactate dehydrogenase from the malarial parasite Plasmodium falciparum (pLDH). All inhibitors are competitive with the binding of NADH. Selectivity for LDH-H, LDH-M, or pLDH is strongly dependent upon the groups that are in the 4- and 7-positions of the dihydroxynaphthoic acid backbone. Dissociation constants as low as 50 nM were observed, with selectivity as high as 400-fold.

摘要

合成了倍半萜8-脱氧半棉子酸(2,3-二羟基-6-甲基-4-(1-甲基乙基)-1-萘甲酸)的衍生物,这些衍生物在4-位含有改变的烷基,在7-位含有烷基或芳烷基。这些取代的二羟基萘甲酸是人乳酸脱氢酶-H(LDH-H)、LDH-M以及疟原虫恶性疟原虫乳酸脱氢酶(pLDH)的选择性抑制剂。所有抑制剂与NADH的结合具有竞争性。对LDH-H、LDH-M或pLDH的选择性强烈依赖于二羟基萘甲酸主链4-位和7-位的基团。观察到解离常数低至50 nM,选择性高达400倍。

相似文献

1
Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum.人类乳酸脱氢酶及恶性疟原虫乳酸脱氢酶的选择性抑制剂。
J Med Chem. 1998 Sep 24;41(20):3879-87. doi: 10.1021/jm980334n.
2
Comparative structural analysis and kinetic properties of lactate dehydrogenases from the four species of human malarial parasites.四种人类疟原虫乳酸脱氢酶的比较结构分析及动力学特性
Biochemistry. 2004 May 25;43(20):6219-29. doi: 10.1021/bi049892w.
3
Substrate and cofactor specificity and selective inhibition of lactate dehydrogenase from the malarial parasite P. falciparum.恶性疟原虫乳酸脱氢酶的底物、辅因子特异性及选择性抑制作用
Mol Biochem Parasitol. 1997 Dec 1;90(1):235-46. doi: 10.1016/s0166-6851(97)00140-0.
4
Design, synthesis, and biological evaluation of Plasmodium falciparum lactate dehydrogenase inhibitors.恶性疟原虫乳酸脱氢酶抑制剂的设计、合成及生物学评价
J Med Chem. 2007 Aug 9;50(16):3841-50. doi: 10.1021/jm070336k. Epub 2007 Jul 18.
5
Mapping the binding site for gossypol-like inhibitors of Plasmodium falciparum lactate dehydrogenase.绘制恶性疟原虫乳酸脱氢酶的棉酚样抑制剂的结合位点图谱。
Mol Biochem Parasitol. 2005 Aug;142(2):137-48. doi: 10.1016/j.molbiopara.2005.03.015. Epub 2005 Apr 18.
6
Generation of oxamic acid libraries: antimalarials and inhibitors of Plasmodium falciparum lactate dehydrogenase.草氨酸文库的生成:抗疟药及恶性疟原虫乳酸脱氢酶抑制剂
J Comb Chem. 2007 Mar-Apr;9(2):292-300. doi: 10.1021/cc060110n. Epub 2007 Feb 23.
7
Plasmodium and host lactate dehydrogenase molecular function and biological pathways: implication for antimalarial drug discovery.疟原虫与宿主乳酸脱氢酶的分子功能及生物学途径:对抗疟药物研发的启示
Chem Biol Drug Des. 2007 Apr;69(4):280-3. doi: 10.1111/j.1747-0285.2007.00495.x.
8
The kinetic properties and sensitivities to inhibitors of lactate dehydrogenases (LDH1 and LDH2) from Toxoplasma gondii: comparisons with pLDH from Plasmodium falciparum.刚地弓形虫乳酸脱氢酶(LDH1和LDH2)的动力学特性及对抑制剂的敏感性:与恶性疟原虫pLDH的比较
Mol Biochem Parasitol. 2001 Nov;118(1):23-32. doi: 10.1016/s0166-6851(01)00360-7.
9
Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C4.人乳酸脱氢酶A4、B4和C4的选择性活性位点抑制剂。
Biochem Pharmacol. 2001 Jul 1;62(1):81-9. doi: 10.1016/s0006-2952(01)00636-0.
10
Structure and function of Plasmodium falciparum malate dehydrogenase: role of critical amino acids in co-substrate binding pocket.恶性疟原虫苹果酸脱氢酶的结构与功能:关键氨基酸在辅酶结合口袋中的作用。
Biochimie. 2009 Nov-Dec;91(11-12):1509-17. doi: 10.1016/j.biochi.2009.09.005. Epub 2009 Sep 20.

引用本文的文献

1
A review on the ethnomedicinal plants used for the traditional treatment of malaria in the Mayurbhanj district of Odisha, India.印度奥里萨邦梅奥尔布汉杰地区用于传统疟疾治疗的民族药用植物综述。
Malar J. 2025 Jul 12;24(1):228. doi: 10.1186/s12936-025-05477-5.
2
Design and screening of novel molecular compounds targeting lactate dehydrogenase of Babesia microti.针对微小巴贝斯虫乳酸脱氢酶的新型分子化合物的设计与筛选
Parasit Vectors. 2025 Feb 23;18(1):69. doi: 10.1186/s13071-024-06623-9.
3
Lactate produced by alveolar type II cells suppresses inflammatory alveolar macrophages in acute lung injury.
肺泡 II 型细胞产生的乳酸抑制急性肺损伤中的炎症性肺泡巨噬细胞。
FASEB J. 2023 Dec;37(12):e23316. doi: 10.1096/fj.202301722R.
4
Warburg effect in colorectal cancer: the emerging roles in tumor microenvironment and therapeutic implications.结直肠癌中的瓦博格效应:在肿瘤微环境中的新兴作用及其治疗意义。
J Hematol Oncol. 2022 Nov 1;15(1):160. doi: 10.1186/s13045-022-01358-5.
5
MYCN and Metabolic Reprogramming in Neuroblastoma.MYCN与神经母细胞瘤中的代谢重编程
Cancers (Basel). 2022 Aug 25;14(17):4113. doi: 10.3390/cancers14174113.
6
Immune effects of PI3K/Akt/HIF-1α-regulated glycolysis in polymorphonuclear neutrophils during sepsis.PI3K/Akt/HIF-1α 调控糖酵解在脓毒症中性粒细胞中的免疫作用。
Crit Care. 2022 Jan 28;26(1):29. doi: 10.1186/s13054-022-03893-6.
7
Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies.靶向葡萄糖或谷氨酰胺代谢疗法联合PD-1/PD-L1检查点阻断免疫疗法治疗肿瘤——机制与策略
Front Oncol. 2021 Jul 13;11:697894. doi: 10.3389/fonc.2021.697894. eCollection 2021.
8
Investigation of Inhibition Effect of Gossypol-Acetic Acid on Gastric Cancer Cells Based on a Network Pharmacology Approach and Experimental Validation.基于网络药理学方法和实验验证研究醋酸棉酚对胃癌细胞的抑制作用。
Drug Des Devel Ther. 2020 Sep 7;14:3615-3623. doi: 10.2147/DDDT.S256566. eCollection 2020.
9
Identifying the Naphthalene-Based Compound 3,5-Dihydroxy 2-Napthoic Acid as a Novel Lead Compound for Designing Lactate Dehydrogenase-Specific Antibabesial Drug.鉴定基于萘的化合物3,5-二羟基-2-萘甲酸为设计乳酸脱氢酶特异性抗巴贝斯虫药物的新型先导化合物。
Front Pharmacol. 2020 Jan 30;10:1663. doi: 10.3389/fphar.2019.01663. eCollection 2019.
10
FX11 limits growth and potentiates bactericidal activity of isoniazid through host-directed activity.FX11 通过宿主导向活性限制异烟肼的生长并增强其杀菌活性。
Dis Model Mech. 2020 Mar 30;13(3):dmm041954. doi: 10.1242/dmm.041954.